Based on new #ACR20 RA guidelines, will you @rheumnow

Georgeous day in Dallas! Taking a break from #ACR20 and having a socially distanced lunch with the boss! No injuries noted. Wish you here with us! @uptoTate @Rheumnow https://t.co/7Xo8JoG5Fq

Amazing lecture by Dr Jane Salmon for the RRF memorial foundation to honor Dr Shaun Ruddy #ACR20 @HSpecialSurgery @RheumNow the IMPACT study - pregnancy in APS with Certolizumab Therapy https://t.co/A9U11qI7zG

Back in my clinic today at GMT (+5 EST) and applying the new knowledge from #ACR20 ran a hybrid clinic with face to face, telephone and video consultations all rolled into one. Now time to catch up with Day 4 of ACR Convergence with @RheumNow #virtual #hybrid

#ACR20 imaging competition: 27 yo F with h/o SLE nephritis s/p kidney transplant p/w abdominal pain due to abdominal wall tophus @RheumNow. https://t.co/iDlF3neIYM

Tocilizumab NOT effective in preventing mechanical ventilation or death in moderately ill COVID-19 pts. Double-blind, Placebo, RCT (n=243) @RheumNow #ACR20 Abs#L07 #ACRbest https://t.co/juSQRCnTeD

Worth checking out the #ACR20 image competition. Here's an image of cerebral toxoplasmosis during ADA treatment for RA @RheumNow. https://t.co/APPlumeUtA

The FAST trial had 33% of pts with CVD and pts w/class III/IV CHF were not allowed in this study (vs. CARES trial where all subjects had baseline CVD); I am still cautious prescribing febuxostat to pts who have severe CVD until we have more data. @RheumNow https://t.co/fJ9bLcXpR2

• https://twitter.com/drdavidliew/status/1325850326302224385

#ACR20 Abs#L11. Efficacy of TOFA vs PBO in AS. At week 16, %ASAS20 responders 56% v 29% PBO; %ASAS40 40% vs 12%. @RheumNow #ACRBest https://t.co/3Faj64rBjd

Large cohort of older RA pts newly rx w/HCQ or MTX: 👉~2-fold ⬆ risk of VTE – both PE and DVT- among patients newly treated with MTX vs. HCQ. @RheumNow #ACR20 abs#2000 @DanielHSolomon https://t.co/ZnDuMhTMYF

"The goal of a vaccine is not just to protect a (vaccinated) individual, but to end the pandemic." Dr. Dan Barouch #ACR20 @RheumNow

HCQ not associated with ⬆ incidence of cardiac dse in this cohort of RA pts. We should continue using it. Benefits >>>risks. @RheumNow #ACR20 abs1999 https://t.co/zYpbX0CsR1

Industry Abstract Previews - #ACR20 https://t.co/IiF0Md8XXk https://t.co/7qmqwQcgOa

• https://bit.ly/3n0LzdS

What a great interview with @IreneBlancoMD regarding equity and inclusion in rheumatology. She is amazing! Such an important topic for all of us! #ACR20 @rheumnow https://t.co/cmRfXVGGDJ

• Equity and Inclusion in Rheumatology Education: Dr. Irene Blanco | RheumNow